Watcha Mehernoor F
Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, 34th Street and Civic Center Boulevard, Philadelphia, PA 19104, USA.
Anesthesiol Clin North Am. 2002 Sep;20(3):709-722. doi: 10.1016/s0889-8537(02)00010-x.
Watcha and White [51] have made recommendations for antiemetic therapy and prophylaxis based on published peer-reviewed studies. They range from no prophylaxis for patients at low risk to "multimodal" antiemetic therapy for those at the highest risk (Fig. 1) [10]. Recommendations for rescue therapy of breakthrough PONV are also provided. With this approach, it should be possible [figure: see text] to individualize prophylaxis and rescue therapy to achieve an optimal cost-effective management strategy for this uncomfortable postoperative complication.
瓦查和怀特[51]根据已发表的同行评审研究,对止吐治疗和预防提出了建议。这些建议范围从对低风险患者不进行预防,到对高风险患者采用“多模式”止吐治疗(图1)[10]。还提供了突破性术后恶心呕吐(PONV)的挽救治疗建议。通过这种方法,应该有可能[图:见正文]针对个体进行预防和挽救治疗,从而为这种令人不适的术后并发症制定出最佳的性价比管理策略。